Trial intelligence / Profile preview

Phase 3 open-label study of LX-P (loxoprofen tape) in patients with various pains

jRCT2080222338Phase 3

Sponsor
Lead Chemical
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of loxoprofen in pain, sponsored by Lead Chemical.

02

Drugs

loxoprofen
03

Conditions

pain

Beyond the preview

Go deeper on jRCT2080222338.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222338.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call